RFI_IIWM.pdf

COURT SERVICES AND OFFENDER SUPERVISION AGENCY | REQUEST FOR INFORMATION

REQUEST FOR INFORMATION

Medically Managed Intensive Residential Withdrawal Management (IIWM) Services

12-Month Base Period Plus Four 12-Month Option Periods

Agency Court Services and Offender Supervision Agency (CSOSA)

RFI Number 9594CS27Q0004RFI

NAICS Code 623220 Residential Mental Health and Substance Abuse Facilities

Issue Date November 4, 2026

Response Due December 3, 2026

Contracting Contact Colin Lee, Contract Specialist, colin.lee@csosa.gov, (202) 220-5621

IMPORTANT: This notice is issued solely for market research and acquisition planning. It is not a solicitation, request for proposals, invitation for bids, or commitment by the Government to award a contract. The Government will not reimburse respondents for costs incurred in preparing or submitting information.

mailto:colin.lee@csosa.gov

1. Purpose of This Request for Information The Court Services and Offender Supervision Agency (CSOSA) is conducting market research to identify qualified sources capable of providing Medically Managed Intensive Residential Withdrawal Management (IIWM) services for individuals referred by CSOSA. The Government seeks information regarding industry capability, facility capacity, clinical and medical staffing, licensing and accreditation, geographic availability, transportation, transition planning, performance measurement, and potential pricing approaches.

The anticipated acquisition would include one 12-month base period and four 12-month option periods, for a potential total period of performance of 60 months. Responses will help CSOSA assess the availability of responsible sources, consider an appropriate acquisition strategy, refine performance requirements, and determine whether a small-business set-aside or another socioeconomic strategy is suitable.

2. Agency Background CSOSA is a Federal Executive Branch agency responsible for probation, parole, and supervised-release functions in the District of Columbia. CSOSA’s mission includes increasing public safety, reducing recidivism, supporting the fair administration of justice, and collaborating with community partners to address the needs of individuals under supervision.

3. Anticipated Requirement The contemplated requirement is for medically managed, intensive residential withdrawal management and related stabilization services. The Contractor would provide appropriately licensed medical, nursing, clinical, case management, direct care, and support personnel capable of safely serving patients experiencing acute withdrawal signs and symptoms, including those with behavioral health and other co-occurring conditions.

• Provide, at a minimum, care consistent with ASAM Level 3.7 when clinically indicated and authorized by

CSOSA.

• Maintain 24-hour residential supervision, monitoring, access to nursing and medical services, medication management, and emergency response capability.

• Conduct timely referral review, intake, medical and nursing assessments, toxicology testing, suicide-risk screening, treatment planning, daily progress documentation, and discharge planning.

• Use evidence-based therapeutic interventions, including cognitive behavioral approaches, motivational enhancement, relapse prevention, coping-skills development, and pro-social programming.

• Coordinate closely with CSOSA personnel, receiving providers, hospitals, and other authorized stakeholders while protecting personally identifiable information and protected health information.

• Provide transportation from designated pickup locations and to approved discharge destinations.

• Provide meals, linens, toiletries, laundry access, facility safety and security, special and therapeutic diets, language assistance, and continuity-of-operations arrangements.

4. Place of Performance and Service Area The facility must be located within a 30-mile radius of 633 Indiana Avenue NW, Washington, DC 20004-2902.

CSOSA anticipates referring supervisees to treatment facilities in the District of Columbia; Montgomery, Prince George’s, and Charles Counties in Maryland; Arlington County, Virginia; and the City of Alexandria, Virginia.

5. Anticipated Period of Performance Period Duration Estimated Timing

Period Duration Estimated Timing

Base Period 12 months To Be Determined

Option Period 1 12 months To Be Determined

Option Period 2 12 months To Be Determined

Option Period 3 12 months To Be Determined

Option Period 4 12 months To Be Determined

6. Planning Assumptions

• The anticipated initial withdrawal-management episode is generally three to seven days, subject to clinical need and written CSOSA authorization.

• Authorized services for an individual patient may extend up to 183 days when clinically appropriate and approved by CSOSA.

• Referral quantities and patient days are estimates and are not guaranteed.

• The Government anticipates a performance objective under which at least 90 percent of eligible patients successfully complete the authorized program, using a final definition and methodology established in the solicitation and Quality Assurance Surveillance Plan.

• Only services supported by a written referral and billing authorization would be reimbursable.

7. Minimum Capability Areas

Clinical and Medical Capability

• Physician oversight and on-call availability 24 hours per day

• Registered nursing and medication-management capability

• Assessment and treatment of withdrawal, co-occurring conditions, pregnancy, polysubstance use, benzodiazepine dependence, and patients receiving medications for opioid use disorder

• Hospital affiliation and emergency-transfer procedures

Licensing and Accreditation

• Current jurisdictional licenses for the facility and services provided

• Current accreditation by The Joint Commission or CARF International

• Qualified, licensed, credentialed, and background-cleared personnel

• Compliance with applicable Federal, state, and local requirements

Program Operations

• 24/7/365 staffing and facility operations

• Individualized assessment, treatment planning, structured programming, counseling, case management, progress notes, and discharge planning

• Secure records management consistent with 42 CFR Part 2, HIPAA as applicable, the Privacy Act as applicable, and CSOSA requirements

• Quality control, incident reporting, monthly program reporting, and corrective-action capability

Facility and Support Services

• Safe, secure, accessible residential environment

• Transportation capability

• Food service, therapeutic and special diets, linens, toiletries, and laundry access

• Language assistance and accommodations for individuals who are deaf or hard of hearing

• Continuity of Operations Plan and alternate housing capability

8. Information Requested from Respondents Respondents should address each item below in the order presented. Concise responses are encouraged. If an item does not apply, state “Not Applicable” and briefly explain.

1. Company Information

Legal business name; headquarters and local facility address; Unique Entity Identifier (if registered in SAM.gov);

CAGE code; website; primary point of contact; business size and socioeconomic status; proposed NAICS code; and whether the respondent is registered in SAM.gov.

2. Facility Location and Capacity

Identify each proposed facility, its distance from 633 Indiana Avenue NW, Washington, DC, licensed bed capacity, average available capacity, surge capacity, gender-specific or co-ed configuration, accessibility features, and ability to reserve or prioritize beds for CSOSA referrals.

3. Licenses and Accreditation

List current facility and professional licenses, issuing authorities, expiration dates, and current Joint Commission or CARF accreditation. Identify any material corrective actions, suspensions, or restrictions during the past three years.

4. Clinical Model

Describe the clinical model and ability to provide ASAM Level 3.7 services, including withdrawal protocols, physician and nursing coverage, medication management, suicide-risk assessment, laboratory and toxicology services, treatment planning, counseling, structured programming, and transition to the next level of care.

5. Staffing

Provide a representative staffing plan by shift and patient census, including physicians, registered nurses, clinical supervisors, case managers, counselors/therapists, and direct-care staff. Explain recruitment, credential verification, background checks, training, turnover mitigation, and contingency staffing.

6. Higher-Acuity and Special Populations

Describe capability and limitations for pregnant patients, sex offender limitations (if any), polysubstance use, benzodiazepine withdrawal, medications for opioid use disorder, co-occurring behavioral health conditions, non-life-threatening medical conditions, mobility limitations, and language or communication needs.

7. Hospital and Emergency Arrangements

Describe hospital affiliation agreements, emergency transportation, transfer procedures, after-hours medical response, and continuity-of-care information exchange.

8. Admissions and Transportation

Describe hours of admission, ability to respond to referrals within 12 hours, expedited-admission capability, acceptance and exclusion criteria, no-show management, and transportation fleet, drivers, insurance, and geographic coverage.

9. Records, Privacy, and Security

Describe electronic medical record capabilities, access controls, secure transmission, separation of CSOSA records, incident response, closed-file transfer, records retention, and compliance with 42 CFR Part 2, HIPAA as applicable, and other privacy and security requirements.

10. Performance and Quality

Describe quality-control processes, outcome measurement, successful-completion rates for comparable programs, complaint and incident management, patient satisfaction, audit readiness, corrective-action processes, and ability to support a 90 percent completion objective.

11. Past Performance

Provide up to two recent and relevant contracts or agreements performed within the past five years. Include customer, scope, period, approximate annual value, patient volume, point of contact, and description of relevance.

Do not include protected patient information.

12. Subcontracting and Teaming

Identify anticipated subcontractors, affiliates, or teaming partners; describe their roles; and state which core functions would be self-performed.

13. Pricing and Contract Structure

Recommend an appropriate pricing arrangement, such as a fixed daily bed rate, tiered patient-day rate, minimum bed guarantee, fixed monthly capacity charge, or hybrid model. Identify major cost drivers, customary escalation, assumptions regarding medications and external medical expenses, and invoicing practices.

14. Acquisition Strategy

State whether the respondent could perform as a prime contractor. Provide views on contract type, set-aside feasibility, lead time needed after award, transition risks, and any terms that may unnecessarily restrict competition.

15. Draft Requirement Feedback

Identify ambiguities, conflicting requirements, clinically impractical timelines, licensing concerns, or recommended revisions that would improve patient safety, performance, competition, or cost effectiveness.

9. Requested Rough-Order-of-Magnitude Pricing For planning purposes only, respondents are invited to provide nonbinding rough-order-of-magnitude pricing.

Clearly state all assumptions, exclusions, minimum volumes, and expiration of pricing information.

Period Unit Estimated Quantity Unit Price Extended Amount

Base Period Patient day [Respondent input] $________ $________

Option Period 1 Patient day [Respondent input] $________ $________

Option Period 2 Patient day [Respondent input] $________ $________

Option Period 3 Patient day [Respondent input] $________ $________

Option Period 4 Patient day [Respondent input] $________ $________

Optional alternate pricing model and explanation:

10. Response Format and Page Limit

• Submit the response in searchable PDF format. A Microsoft Word version may also be provided.

• Use 8.5 x 11-inch pages, at least 10-point font, and one-inch margins where practicable.

• Limit the capability response to 20 pages, excluding the cover page, licenses, accreditation certificates, and past-performance references.

• Do not include patient-identifying information, proprietary source-selection information, or classified information.

• Mark proprietary information clearly. The Government will protect properly marked information consistent with applicable law and regulation.

11. Submission Instructions

Email address [INSERT SUBMISSION EMAIL]

Subject line Response to 9594CS27Q0004RFI - IIWM Services - [COMPANY NAME]

Due date and time December 3, 2026, 11 AM ET

Questions due November 11, 2026, 11 AM ET

File naming convention [COMPANY NAME]_IIWM_RFI_Response.pdf

12. Government Disclaimer This RFI is issued for information and planning purposes only and does not constitute a solicitation. Responses are not offers and cannot be accepted by the Government to form a binding contract. The Government is not obligated to issue a solicitation or award a contract as a result of this notice. Respondents are solely responsible for all expenses associated with responding. The Government may use submitted information to refine its acquisition strategy and requirements, subject to applicable protections for proprietary information.